Loading…

Fibronectin (FN) decreases glomerular lesions and synthesis of tumour necrosis factor‐alpha (TNF‐α), platelet‐activating factor (PAF) and FN in proliferative glomerulonephritis

SUMMARY We have studied the effect of therapy with plasma FN on glomerular synthesis of PAF, TNF‐α and FN, in experimental proliferative glomerulonephritis. Glomerular PAF, TNF‐α and FN production were increased in rats with nephritis. Peak glomerular PAF production preceded, while peak glomerular T...

Full description

Saved in:
Bibliographic Details
Published in:Clinical and experimental immunology 1995-08, Vol.101 (2), p.334-340
Main Authors: ORTÍZ, A., ALONSO, J., GÓMEZ‐CHIARRI, M., LERMA, J. L., SERON, D., CONDOM, E., GONZÁLEZ, E., EGIDO, J.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5390-cc96d908869cacbaad7c6a5192c4b001a2849778364aa69aeb1fc2f338e82aa73
cites cdi_FETCH-LOGICAL-c5390-cc96d908869cacbaad7c6a5192c4b001a2849778364aa69aeb1fc2f338e82aa73
container_end_page 340
container_issue 2
container_start_page 334
container_title Clinical and experimental immunology
container_volume 101
creator ORTÍZ, A.
ALONSO, J.
GÓMEZ‐CHIARRI, M.
LERMA, J. L.
SERON, D.
CONDOM, E.
GONZÁLEZ, E.
EGIDO, J.
description SUMMARY We have studied the effect of therapy with plasma FN on glomerular synthesis of PAF, TNF‐α and FN, in experimental proliferative glomerulonephritis. Glomerular PAF, TNF‐α and FN production were increased in rats with nephritis. Peak glomerular PAF production preceded, while peak glomerular TNF‐α bioactivity coincided with maximal proteinuria. Rats treated with FN (5 mg/kg per 48 h) for 15 days had less proteinuria, glomerular and interstitial cell infiltration and glomerular PAF, TNF‐α and FN synthesis than non‐treated rats. In order to characterize further the mechanisms of action of FN, healthy rats were injected with either FN or saline. Peripheral blood mononuclear cells and neutrophils from healthy rats injected with FN secreted less TNF‐α and PAF, respectively, than those obtained from saline‐treated rats. Our data suggest that the beneficial effect of FN may be related to decreased number of glomerular leucocytes and decreased synthesis of inflammatory mediators and extracellular matrix.
doi_str_mv 10.1111/j.1365-2249.1995.tb08360.x
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1553248</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77464144</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5390-cc96d908869cacbaad7c6a5192c4b001a2849778364aa69aeb1fc2f338e82aa73</originalsourceid><addsrcrecordid>eNqVUkGO0zAUjRBoKANHQLIQQq1Eip04TswCNKomMNKosBjW1o_rtK7cOGMnZbrjCFyFFbfgEJwEh0YVbJDwxv5-77__bL0oekbwnIT1ajsnKcviJKF8TjjP5l2Fi5Th-d29aHKC7kcTjDGPOcH0YfTI-20oGWPJWXSWM1rkpJhE30tdOdso2ekGTcvlDK2UdAq88mht7E653oBDRnltG4-gWSF_aLpNqD2yNer6ne0dCgLODlc1yM66n1--gmk3gKY3yzIUP77NXqLWQKeM6gYwjNtDGLkeG9D040U5-y1fLlGw0jprdK1cIO3VyUkw2m6c7rR_HD2owXj1ZNzPo0_l5c3ifXz94d3V4uI6llnKcSwlZyuOi4JxCbICWOWSQUZ4ImmFMYGkoDzPw-dRAMZBVaSWSZ2mhSoSgDw9j94cddu-2qmVVE3nwIjW6R24g7Cgxd9IozdibfeCZFma0CIIvBgFnL3tle_ETnupjIFG2d6LPKeMEkoDcfpPIqGsSAua5CxQXx-pw6d7p-qTH4LFkBCxFUMMxBADMSREjAkRd6H56Z8vOrWOkQj48xEHL8HUDhqp_YmWMpLTLA20t0faZ23U4T8MiMXl1XBKfwFR5uDA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1468384276</pqid></control><display><type>article</type><title>Fibronectin (FN) decreases glomerular lesions and synthesis of tumour necrosis factor‐alpha (TNF‐α), platelet‐activating factor (PAF) and FN in proliferative glomerulonephritis</title><source>PubMed Central (Open access)</source><creator>ORTÍZ, A. ; ALONSO, J. ; GÓMEZ‐CHIARRI, M. ; LERMA, J. L. ; SERON, D. ; CONDOM, E. ; GONZÁLEZ, E. ; EGIDO, J.</creator><creatorcontrib>ORTÍZ, A. ; ALONSO, J. ; GÓMEZ‐CHIARRI, M. ; LERMA, J. L. ; SERON, D. ; CONDOM, E. ; GONZÁLEZ, E. ; EGIDO, J.</creatorcontrib><description>SUMMARY We have studied the effect of therapy with plasma FN on glomerular synthesis of PAF, TNF‐α and FN, in experimental proliferative glomerulonephritis. Glomerular PAF, TNF‐α and FN production were increased in rats with nephritis. Peak glomerular PAF production preceded, while peak glomerular TNF‐α bioactivity coincided with maximal proteinuria. Rats treated with FN (5 mg/kg per 48 h) for 15 days had less proteinuria, glomerular and interstitial cell infiltration and glomerular PAF, TNF‐α and FN synthesis than non‐treated rats. In order to characterize further the mechanisms of action of FN, healthy rats were injected with either FN or saline. Peripheral blood mononuclear cells and neutrophils from healthy rats injected with FN secreted less TNF‐α and PAF, respectively, than those obtained from saline‐treated rats. Our data suggest that the beneficial effect of FN may be related to decreased number of glomerular leucocytes and decreased synthesis of inflammatory mediators and extracellular matrix.</description><identifier>ISSN: 0009-9104</identifier><identifier>EISSN: 1365-2249</identifier><identifier>DOI: 10.1111/j.1365-2249.1995.tb08360.x</identifier><identifier>PMID: 7648718</identifier><identifier>CODEN: CEXIAL</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Animals ; Biological and medical sciences ; Extracellular Matrix - drug effects ; Extracellular Matrix - metabolism ; fibronectin ; Fibronectins - biosynthesis ; Fibronectins - pharmacology ; Glomerular Mesangium - drug effects ; Glomerular Mesangium - metabolism ; Glomerulonephritis ; Glomerulonephritis, Membranoproliferative - drug therapy ; Glomerulonephritis, Membranoproliferative - metabolism ; Kidney - cytology ; Kidney - metabolism ; Leukocytes, Mononuclear - metabolism ; Male ; Medical sciences ; necrosis factor ; Nephrology. Urinary tract diseases ; Nephropathies. Renovascular diseases. Renal failure ; Neutrophils - metabolism ; Platelet Activating Factor - biosynthesis ; platelet‐activating factor ; proteinuria ; Rats ; Rats, Wistar ; Tumor Necrosis Factor-alpha - biosynthesis ; tumour</subject><ispartof>Clinical and experimental immunology, 1995-08, Vol.101 (2), p.334-340</ispartof><rights>1995 Blackwell Science Ltd, Oxford</rights><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5390-cc96d908869cacbaad7c6a5192c4b001a2849778364aa69aeb1fc2f338e82aa73</citedby><cites>FETCH-LOGICAL-c5390-cc96d908869cacbaad7c6a5192c4b001a2849778364aa69aeb1fc2f338e82aa73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1553248/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1553248/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3617453$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7648718$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ORTÍZ, A.</creatorcontrib><creatorcontrib>ALONSO, J.</creatorcontrib><creatorcontrib>GÓMEZ‐CHIARRI, M.</creatorcontrib><creatorcontrib>LERMA, J. L.</creatorcontrib><creatorcontrib>SERON, D.</creatorcontrib><creatorcontrib>CONDOM, E.</creatorcontrib><creatorcontrib>GONZÁLEZ, E.</creatorcontrib><creatorcontrib>EGIDO, J.</creatorcontrib><title>Fibronectin (FN) decreases glomerular lesions and synthesis of tumour necrosis factor‐alpha (TNF‐α), platelet‐activating factor (PAF) and FN in proliferative glomerulonephritis</title><title>Clinical and experimental immunology</title><addtitle>Clin Exp Immunol</addtitle><description>SUMMARY We have studied the effect of therapy with plasma FN on glomerular synthesis of PAF, TNF‐α and FN, in experimental proliferative glomerulonephritis. Glomerular PAF, TNF‐α and FN production were increased in rats with nephritis. Peak glomerular PAF production preceded, while peak glomerular TNF‐α bioactivity coincided with maximal proteinuria. Rats treated with FN (5 mg/kg per 48 h) for 15 days had less proteinuria, glomerular and interstitial cell infiltration and glomerular PAF, TNF‐α and FN synthesis than non‐treated rats. In order to characterize further the mechanisms of action of FN, healthy rats were injected with either FN or saline. Peripheral blood mononuclear cells and neutrophils from healthy rats injected with FN secreted less TNF‐α and PAF, respectively, than those obtained from saline‐treated rats. Our data suggest that the beneficial effect of FN may be related to decreased number of glomerular leucocytes and decreased synthesis of inflammatory mediators and extracellular matrix.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Extracellular Matrix - drug effects</subject><subject>Extracellular Matrix - metabolism</subject><subject>fibronectin</subject><subject>Fibronectins - biosynthesis</subject><subject>Fibronectins - pharmacology</subject><subject>Glomerular Mesangium - drug effects</subject><subject>Glomerular Mesangium - metabolism</subject><subject>Glomerulonephritis</subject><subject>Glomerulonephritis, Membranoproliferative - drug therapy</subject><subject>Glomerulonephritis, Membranoproliferative - metabolism</subject><subject>Kidney - cytology</subject><subject>Kidney - metabolism</subject><subject>Leukocytes, Mononuclear - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>necrosis factor</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Nephropathies. Renovascular diseases. Renal failure</subject><subject>Neutrophils - metabolism</subject><subject>Platelet Activating Factor - biosynthesis</subject><subject>platelet‐activating factor</subject><subject>proteinuria</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Tumor Necrosis Factor-alpha - biosynthesis</subject><subject>tumour</subject><issn>0009-9104</issn><issn>1365-2249</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><recordid>eNqVUkGO0zAUjRBoKANHQLIQQq1Eip04TswCNKomMNKosBjW1o_rtK7cOGMnZbrjCFyFFbfgEJwEh0YVbJDwxv5-77__bL0oekbwnIT1ajsnKcviJKF8TjjP5l2Fi5Th-d29aHKC7kcTjDGPOcH0YfTI-20oGWPJWXSWM1rkpJhE30tdOdso2ekGTcvlDK2UdAq88mht7E653oBDRnltG4-gWSF_aLpNqD2yNer6ne0dCgLODlc1yM66n1--gmk3gKY3yzIUP77NXqLWQKeM6gYwjNtDGLkeG9D040U5-y1fLlGw0jprdK1cIO3VyUkw2m6c7rR_HD2owXj1ZNzPo0_l5c3ifXz94d3V4uI6llnKcSwlZyuOi4JxCbICWOWSQUZ4ImmFMYGkoDzPw-dRAMZBVaSWSZ2mhSoSgDw9j94cddu-2qmVVE3nwIjW6R24g7Cgxd9IozdibfeCZFma0CIIvBgFnL3tle_ETnupjIFG2d6LPKeMEkoDcfpPIqGsSAua5CxQXx-pw6d7p-qTH4LFkBCxFUMMxBADMSREjAkRd6H56Z8vOrWOkQj48xEHL8HUDhqp_YmWMpLTLA20t0faZ23U4T8MiMXl1XBKfwFR5uDA</recordid><startdate>199508</startdate><enddate>199508</enddate><creator>ORTÍZ, A.</creator><creator>ALONSO, J.</creator><creator>GÓMEZ‐CHIARRI, M.</creator><creator>LERMA, J. L.</creator><creator>SERON, D.</creator><creator>CONDOM, E.</creator><creator>GONZÁLEZ, E.</creator><creator>EGIDO, J.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>199508</creationdate><title>Fibronectin (FN) decreases glomerular lesions and synthesis of tumour necrosis factor‐alpha (TNF‐α), platelet‐activating factor (PAF) and FN in proliferative glomerulonephritis</title><author>ORTÍZ, A. ; ALONSO, J. ; GÓMEZ‐CHIARRI, M. ; LERMA, J. L. ; SERON, D. ; CONDOM, E. ; GONZÁLEZ, E. ; EGIDO, J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5390-cc96d908869cacbaad7c6a5192c4b001a2849778364aa69aeb1fc2f338e82aa73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Extracellular Matrix - drug effects</topic><topic>Extracellular Matrix - metabolism</topic><topic>fibronectin</topic><topic>Fibronectins - biosynthesis</topic><topic>Fibronectins - pharmacology</topic><topic>Glomerular Mesangium - drug effects</topic><topic>Glomerular Mesangium - metabolism</topic><topic>Glomerulonephritis</topic><topic>Glomerulonephritis, Membranoproliferative - drug therapy</topic><topic>Glomerulonephritis, Membranoproliferative - metabolism</topic><topic>Kidney - cytology</topic><topic>Kidney - metabolism</topic><topic>Leukocytes, Mononuclear - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>necrosis factor</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Nephropathies. Renovascular diseases. Renal failure</topic><topic>Neutrophils - metabolism</topic><topic>Platelet Activating Factor - biosynthesis</topic><topic>platelet‐activating factor</topic><topic>proteinuria</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Tumor Necrosis Factor-alpha - biosynthesis</topic><topic>tumour</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ORTÍZ, A.</creatorcontrib><creatorcontrib>ALONSO, J.</creatorcontrib><creatorcontrib>GÓMEZ‐CHIARRI, M.</creatorcontrib><creatorcontrib>LERMA, J. L.</creatorcontrib><creatorcontrib>SERON, D.</creatorcontrib><creatorcontrib>CONDOM, E.</creatorcontrib><creatorcontrib>GONZÁLEZ, E.</creatorcontrib><creatorcontrib>EGIDO, J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical and experimental immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ORTÍZ, A.</au><au>ALONSO, J.</au><au>GÓMEZ‐CHIARRI, M.</au><au>LERMA, J. L.</au><au>SERON, D.</au><au>CONDOM, E.</au><au>GONZÁLEZ, E.</au><au>EGIDO, J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fibronectin (FN) decreases glomerular lesions and synthesis of tumour necrosis factor‐alpha (TNF‐α), platelet‐activating factor (PAF) and FN in proliferative glomerulonephritis</atitle><jtitle>Clinical and experimental immunology</jtitle><addtitle>Clin Exp Immunol</addtitle><date>1995-08</date><risdate>1995</risdate><volume>101</volume><issue>2</issue><spage>334</spage><epage>340</epage><pages>334-340</pages><issn>0009-9104</issn><eissn>1365-2249</eissn><coden>CEXIAL</coden><abstract>SUMMARY We have studied the effect of therapy with plasma FN on glomerular synthesis of PAF, TNF‐α and FN, in experimental proliferative glomerulonephritis. Glomerular PAF, TNF‐α and FN production were increased in rats with nephritis. Peak glomerular PAF production preceded, while peak glomerular TNF‐α bioactivity coincided with maximal proteinuria. Rats treated with FN (5 mg/kg per 48 h) for 15 days had less proteinuria, glomerular and interstitial cell infiltration and glomerular PAF, TNF‐α and FN synthesis than non‐treated rats. In order to characterize further the mechanisms of action of FN, healthy rats were injected with either FN or saline. Peripheral blood mononuclear cells and neutrophils from healthy rats injected with FN secreted less TNF‐α and PAF, respectively, than those obtained from saline‐treated rats. Our data suggest that the beneficial effect of FN may be related to decreased number of glomerular leucocytes and decreased synthesis of inflammatory mediators and extracellular matrix.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>7648718</pmid><doi>10.1111/j.1365-2249.1995.tb08360.x</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0009-9104
ispartof Clinical and experimental immunology, 1995-08, Vol.101 (2), p.334-340
issn 0009-9104
1365-2249
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1553248
source PubMed Central (Open access)
subjects Animals
Biological and medical sciences
Extracellular Matrix - drug effects
Extracellular Matrix - metabolism
fibronectin
Fibronectins - biosynthesis
Fibronectins - pharmacology
Glomerular Mesangium - drug effects
Glomerular Mesangium - metabolism
Glomerulonephritis
Glomerulonephritis, Membranoproliferative - drug therapy
Glomerulonephritis, Membranoproliferative - metabolism
Kidney - cytology
Kidney - metabolism
Leukocytes, Mononuclear - metabolism
Male
Medical sciences
necrosis factor
Nephrology. Urinary tract diseases
Nephropathies. Renovascular diseases. Renal failure
Neutrophils - metabolism
Platelet Activating Factor - biosynthesis
platelet‐activating factor
proteinuria
Rats
Rats, Wistar
Tumor Necrosis Factor-alpha - biosynthesis
tumour
title Fibronectin (FN) decreases glomerular lesions and synthesis of tumour necrosis factor‐alpha (TNF‐α), platelet‐activating factor (PAF) and FN in proliferative glomerulonephritis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T11%3A36%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fibronectin%20(FN)%20decreases%20glomerular%20lesions%20and%20synthesis%20of%20tumour%20necrosis%20factor%E2%80%90alpha%20(TNF%E2%80%90%CE%B1),%20platelet%E2%80%90activating%20factor%20(PAF)%20and%20FN%20in%20proliferative%20glomerulonephritis&rft.jtitle=Clinical%20and%20experimental%20immunology&rft.au=ORT%C3%8DZ,%20A.&rft.date=1995-08&rft.volume=101&rft.issue=2&rft.spage=334&rft.epage=340&rft.pages=334-340&rft.issn=0009-9104&rft.eissn=1365-2249&rft.coden=CEXIAL&rft_id=info:doi/10.1111/j.1365-2249.1995.tb08360.x&rft_dat=%3Cproquest_pubme%3E77464144%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5390-cc96d908869cacbaad7c6a5192c4b001a2849778364aa69aeb1fc2f338e82aa73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1468384276&rft_id=info:pmid/7648718&rfr_iscdi=true